{"id":355779,"date":"2025-08-29T02:51:24","date_gmt":"2025-08-29T02:51:24","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-haemonetics-corporation\/"},"modified":"2025-08-29T02:51:24","modified_gmt":"2025-08-29T02:51:24","slug":"how-to-buy-haemonetics-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","title":{"rendered":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-355779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Haemonetics Corporation (HAE) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu medikal teknoloji liderine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Haemonetics Corporation (HAE) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu medikal teknoloji liderine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Hayat kurtaran ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeline sahip bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Haemonetics Corporation (HAE), medikal inovasyon ve yat\u0131r\u0131m f\u0131rsat\u0131n\u0131n b\u00fcy\u00fcleyici kesi\u015fim noktas\u0131nda yer al\u0131yor. Bu sadece ba\u015fka bir teknoloji hissesi de\u011fil\u2014hastanelerin ve kan merkezlerinin daha verimli \u00e7al\u0131\u015fmas\u0131na yard\u0131mc\u0131 olurken hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftiren bir \u015firket. HAE'nin neden dikkatinizi hak etti\u011fini ve hayat kurtaran misyonlar\u0131n\u0131n bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Hayat kurtaran ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeline sahip bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Haemonetics Corporation (HAE), medikal inovasyon ve yat\u0131r\u0131m f\u0131rsat\u0131n\u0131n b\u00fcy\u00fcleyici kesi\u015fim noktas\u0131nda yer al\u0131yor. Bu sadece ba\u015fka bir teknoloji hissesi de\u011fil\u2014hastanelerin ve kan merkezlerinin daha verimli \u00e7al\u0131\u015fmas\u0131na yard\u0131mc\u0131 olurken hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftiren bir \u015firket. HAE'nin neden dikkatinizi hak etti\u011fini ve hayat kurtaran misyonlar\u0131n\u0131n bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 HAE Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Haemonetics Corporation (HAE), NYSE'de <strong>55,03 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fu: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck tarihiniz. \u015eirketin bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih bu ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiledi\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 HAE Hissesini Nas\u0131l Etkiler?<\/h3> <p>Son d\u00f6nemlere bak\u0131ld\u0131\u011f\u0131nda, HAE finansal haberlere kar\u015f\u0131 dramatik tepkiler vermi\u015ftir. En son 2026 1. \u00e7eyrek kazan\u00e7lar\u0131 7 A\u011fustos 2025'te a\u00e7\u0131kland\u0131 ve beklentileri a\u015fmas\u0131na ra\u011fmen b\u00fcy\u00fck bir hareket yaratt\u0131. \u015eirket, hisse ba\u015f\u0131na <strong>1,10 $ kazan\u00e7<\/strong> a\u00e7\u0131klayarak 1,01 $ olan konsens\u00fcs tahminini 0,09 $ a\u015ft\u0131; gelir ise 321,39 milyon $ ile beklentilerin \u00fczerinde ger\u00e7ekle\u015fti ancak y\u0131ll\u0131k bazda %4,4 d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131<a href=\"https:\/\/www.perplexity.ai\/finance\/HAE\/history\">(Hisse Analizi)<\/a>.<\/p> <p>Piyasalar\u0131n tepkisi ise ilgin\u00e7ti: bu sonu\u00e7lar\u0131n ard\u0131ndan <strong>piyasa \u00f6ncesi %21,85 d\u00fc\u015f\u00fc\u015f<\/strong> ya\u015fand\u0131 ve hisse fiyat\u0131 52 haftal\u0131k dip seviyesine yakla\u015ft\u0131. Bu sa\u011flam temel g\u00f6stergeler ile piyasa duyarl\u0131l\u0131\u011f\u0131 aras\u0131ndaki uyumsuzluk, bilgili yat\u0131r\u0131mc\u0131lar i\u00e7in f\u0131rsatlar yarat\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>HAE'nin son performans\u0131 bir medikal drama gibi\u2014d\u00f6neme\u00e7ler, s\u00fcrprizler ve beklenmedik geli\u015fmelerle dolu:<\/p> <p><strong>Ocak-Mart 2025<\/strong>: Hisse, \u015firketin plazma teknolojisindeki stratejik vizyonunu uygulamaya devam etmesiyle 60 dolar band\u0131ndan y\u00fckseli\u015f kazand\u0131.<\/p> <p><strong>Nisan-Haziran 2025<\/strong>: HAE, yat\u0131r\u0131mc\u0131 g\u00fcveninin medikal teknoloji yeniliklerine artmas\u0131yla Temmuz ba\u015f\u0131nda hisse ba\u015f\u0131na neredeyse <strong>80 $<\/strong> seviyelerine ula\u015ft\u0131.<\/p> <p><strong>Temmuz-A\u011fustos 2025<\/strong>: Dramatik bir geri \u00e7ekilme ya\u015fand\u0131 ve hisse fiyat\u0131 yakla\u015f\u0131k <strong>%30 d\u00fc\u015f\u00fc\u015fle<\/strong> \u015fu anki 55 $ seviyelerine geriledi<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/\">(Hisse Analizi)<\/a>.<\/p> <p>Bu volatilitenin nedenleri aras\u0131nda portf\u00f6y ge\u00e7i\u015f riskleri, marj bask\u0131lar\u0131 ve sa\u011fl\u0131k sekt\u00f6r\u00fc hisselerini etkileyen genel piyasa belirsizlikleri yer ald\u0131. Ancak \u00f6nemli olan nokta, \u015firketin temel g\u00f6stergelerinin bu ini\u015f \u00e7\u0131k\u0131\u015flar boyunca g\u00fc\u00e7l\u00fc kalmas\u0131d\u0131r.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Analistler, HAE'nin uzun vadeli beklentileri konusunda b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser. Uzmanlar\u0131n \u00f6ng\u00f6r\u00fcleri \u015funlar:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 64-68 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %16-23 y\u00fckseli\u015f)<\/li> <li><strong>2026 Tahmini<\/strong>: 86-94 $ ortalama hedef (potansiyel %56-70 b\u00fcy\u00fcme)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: Plazma teknolojisi benimsenmesinin h\u0131zlanmas\u0131yla 95-110 $ aral\u0131\u011f\u0131<\/li> <li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: K\u00fcresel sa\u011fl\u0131k taleplerinin artmas\u0131yla 100-116 $ potansiyel<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/forecast\/\">(Analist Konsens\u00fcs\u00fc)<\/a><\/li> <\/ul> <p>Konsens\u00fcs? <strong>G\u00dc\u00c7L\u00dc AL<\/strong>. Hisseyi takip eden dokuz analist, ortalama fiyat hedefini <strong>103,56 $<\/strong> olarak belirlemi\u015f ve bu da mevcut seviyelerden yakla\u015f\u0131k %88 y\u00fckseli\u015f potansiyeline i\u015faret ediyor<a href=\"https:\/\/stocksguide.com\/en\/forecast\/Haemonetics-Corporation-US4050241003\">(StocksGuide)<\/a>.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Gelir Rehberli\u011fi<\/strong>: \u015eirket 2026 i\u00e7in %3-6 gelir d\u00fc\u015f\u00fc\u015f\u00fc bekliyor<\/li> <li><strong>Piyasa Konsantrasyonu<\/strong>: %80 ABD plazma don\u00f6r sistemlerine ba\u011f\u0131ml\u0131l\u0131k<\/li> <li><strong>Uygulama Bo\u015fluklar\u0131<\/strong>: \u0130\u015f segmentleri aras\u0131nda ge\u00e7i\u015f riskleri<\/li> <li><strong>Volatilite<\/strong>: G\u00fcnl\u00fck fiyat dalgalanmalar\u0131 ortalama %2,71<a href=\"https:\/\/stockinvest.us\/stock\/HAE\">(StockInvest)<\/a><\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>G\u00fc\u00e7l\u00fc Marjlar<\/strong>: %16,8 i\u015fletme marj\u0131 ile rakiplerin \u00fczerinde performans<\/li> <li><strong>\u0130novasyon Liderli\u011fi<\/strong>: FDA onayl\u0131 plazma toplama geli\u015ftirmeleri<\/li> <li><strong>Kurumsal G\u00fcven<\/strong>: B\u00fcy\u00fck yat\u0131r\u0131mc\u0131lar taraf\u0131ndan %400'\u00fcn \u00fczerinde hisse art\u0131\u015f\u0131<\/li> <li><strong>Geri Al\u0131m Program\u0131<\/strong>: 150 milyon $ hisse geri al\u0131m yetkisi<a href=\"https:\/\/www.ainvest.com\/news\/haemonetics-hae-dislocated-market-opportunity-earnings-strength-full-year-guidance-2508\/\">(AInvest)<\/a><\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine d\u00fczenli sabit miktarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: 6 Kas\u0131m kazan\u00e7 raporu \u00e7evresinde potansiyel giri\u015f noktalar\u0131n\u0131 izleyin<\/li> <li><strong>Temelleri Ara\u015ft\u0131r\u0131n<\/strong>: Hissenin arkas\u0131ndaki plazma teknolojisi hikayesini anlay\u0131n<\/li> <li><strong>Uygun \u00c7e\u015fitlendirme<\/strong>: HAE'yi dengeli bir sa\u011fl\u0131k portf\u00f6y\u00fcn\u00fcn par\u00e7as\u0131 olarak tutun<\/li> <\/ol> <p>Esprili t\u00fcccar bilgeli\u011fi: \"HAE ticareti yapmak plazma ba\u011f\u0131\u015f\u0131 gibidir\u2014bazen hafif bir ac\u0131 hissedersiniz ama hayat kurtarmaya yard\u0131m ederken potansiyel olarak para kazan\u0131rs\u0131n\u0131z!\"<\/p> <h2>\u2705 Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NYSE listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"HAE\" Aramas\u0131 Yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Emir detaylar\u0131n\u0131 iki kez kontrol edin ve onaylay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Sa\u011fl\u0131k Hisseleri \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2> <p>Haemonetics gibi \u015firketlere yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option, sa\u011fl\u0131k sekt\u00f6r\u00fc yat\u0131r\u0131mlar\u0131yla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile medikal inovasyon hisselerinde pozisyon almaya ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci sayesinde h\u0131zl\u0131ca i\u015flem yapmaya ba\u015flayabilirsiniz<\/li> <li><strong>Esnek Para \u00c7ekme<\/strong>: Geleneksel ve dijital dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fc analizi ve piyasa i\u00e7g\u00f6r\u00fclerine eri\u015fim<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck mebla\u011flar yat\u0131rmadan umut vadeden sa\u011fl\u0131k \u015firketlerinde kademeli pozisyonlar olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Haemonetics: Medikal Teknoloji Lideri<\/h2> <p>Haemonetics Corporation, ola\u011fan\u00fcst\u00fc bir hikayeye sahip k\u00fcresel bir medikal teknoloji yenilik\u00e7isidir. \u015eirket, kritik sa\u011fl\u0131k ihtiya\u00e7lar\u0131na dokunan \u00fc\u00e7 ana segmentte faaliyet g\u00f6stermektedir:<\/p> <ul> <li><strong>Plazma Operasyonlar\u0131<\/strong>: NexSys PCS sistemleri, FDA onayl\u0131 geli\u015ftirmelerle prosed\u00fcr s\u00fcrelerini sadece 33-38 dakikaya d\u00fc\u015f\u00fcren en son teknoloji plazma toplama sistemidir<a href=\"https:\/\/www.biospace.com\/haemonetics-receives-fda-clearance-for-enhancements-to-nexsys-pcs-plasma-collection-system\">(BioSpace)<\/a>.<\/li> <li><strong>Kan Merkezi \u00c7\u00f6z\u00fcmleri<\/strong>: Kan toplama organizasyonlar\u0131n\u0131n kan g\u00fcvenli\u011fini sa\u011flamalar\u0131na ve operasyonel verimlili\u011fi art\u0131rmalar\u0131na yard\u0131mc\u0131 olur.<\/li> <li><strong>Hastane Teknolojileri<\/strong>: Hemostaz tan\u0131 sistemleri, transf\u00fczyon y\u00f6netim yaz\u0131l\u0131mlar\u0131 ve h\u00fccre kurtarma sistemleri ile hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirir.<\/li> <\/ul> <p>Sistemlerinde 50 milyondan fazla ger\u00e7ek d\u00fcnya toplamas\u0131 tamamlanm\u0131\u015f ve yakla\u015f\u0131k 95 \u00fclkede varl\u0131k g\u00f6steren Haemonetics, sa\u011fl\u0131k verimlili\u011finde g\u00fcvenilir bir ortak olarak kendini kan\u0131tlam\u0131\u015ft\u0131r<a href=\"https:\/\/www.haemonetics.com\/about-us\">(Haemonetics)<\/a>.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Haemonetics'in IMPACT \u00e7al\u0131\u015fmas\u0131\u2014plazmaferez \u00fczerine en b\u00fcy\u00fck klinik denemelerden biri\u20143.443 don\u00f6r\u00fc kapsad\u0131 ve ba\u011f\u0131\u015f ba\u015f\u0131na toplanan plazma hacminde %8,2 art\u0131\u015f g\u00f6sterirken \u00fcst\u00fcn g\u00fcvenlik standartlar\u0131n\u0131 korudu<a href=\"https:\/\/www.stocktitan.net\/news\/HAE\/haemonetics-clinical-study-results-on-a-new-personalized-approach-to-v9whyyljwxi7.html\">(StockTitan)<\/a>. Bu yenilik, ba\u011f\u0131\u015f\u0131kl\u0131k bozukluklar\u0131ndan travma bak\u0131m\u0131na kadar bir\u00e7ok tedavi i\u00e7in artan k\u00fcresel plazma kaynakl\u0131 terapi talebine do\u011frudan yan\u0131t vermektedir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 HAE Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Haemonetics Corporation (HAE), NYSE&#8217;de <strong>55,03 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fu: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck tarihiniz. \u015eirketin bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih bu ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiledi\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 HAE Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>Son d\u00f6nemlere bak\u0131ld\u0131\u011f\u0131nda, HAE finansal haberlere kar\u015f\u0131 dramatik tepkiler vermi\u015ftir. En son 2026 1. \u00e7eyrek kazan\u00e7lar\u0131 7 A\u011fustos 2025&#8217;te a\u00e7\u0131kland\u0131 ve beklentileri a\u015fmas\u0131na ra\u011fmen b\u00fcy\u00fck bir hareket yaratt\u0131. \u015eirket, hisse ba\u015f\u0131na <strong>1,10 $ kazan\u00e7<\/strong> a\u00e7\u0131klayarak 1,01 $ olan konsens\u00fcs tahminini 0,09 $ a\u015ft\u0131; gelir ise 321,39 milyon $ ile beklentilerin \u00fczerinde ger\u00e7ekle\u015fti ancak y\u0131ll\u0131k bazda %4,4 d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131<a href=\"https:\/\/www.perplexity.ai\/finance\/HAE\/history\">(Hisse Analizi)<\/a>.<\/p>\n<p>Piyasalar\u0131n tepkisi ise ilgin\u00e7ti: bu sonu\u00e7lar\u0131n ard\u0131ndan <strong>piyasa \u00f6ncesi %21,85 d\u00fc\u015f\u00fc\u015f<\/strong> ya\u015fand\u0131 ve hisse fiyat\u0131 52 haftal\u0131k dip seviyesine yakla\u015ft\u0131. Bu sa\u011flam temel g\u00f6stergeler ile piyasa duyarl\u0131l\u0131\u011f\u0131 aras\u0131ndaki uyumsuzluk, bilgili yat\u0131r\u0131mc\u0131lar i\u00e7in f\u0131rsatlar yarat\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>HAE&#8217;nin son performans\u0131 bir medikal drama gibi\u2014d\u00f6neme\u00e7ler, s\u00fcrprizler ve beklenmedik geli\u015fmelerle dolu:<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: Hisse, \u015firketin plazma teknolojisindeki stratejik vizyonunu uygulamaya devam etmesiyle 60 dolar band\u0131ndan y\u00fckseli\u015f kazand\u0131.<\/p>\n<p><strong>Nisan-Haziran 2025<\/strong>: HAE, yat\u0131r\u0131mc\u0131 g\u00fcveninin medikal teknoloji yeniliklerine artmas\u0131yla Temmuz ba\u015f\u0131nda hisse ba\u015f\u0131na neredeyse <strong>80 $<\/strong> seviyelerine ula\u015ft\u0131.<\/p>\n<p><strong>Temmuz-A\u011fustos 2025<\/strong>: Dramatik bir geri \u00e7ekilme ya\u015fand\u0131 ve hisse fiyat\u0131 yakla\u015f\u0131k <strong>%30 d\u00fc\u015f\u00fc\u015fle<\/strong> \u015fu anki 55 $ seviyelerine geriledi<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/\">(Hisse Analizi)<\/a>.<\/p>\n<p>Bu volatilitenin nedenleri aras\u0131nda portf\u00f6y ge\u00e7i\u015f riskleri, marj bask\u0131lar\u0131 ve sa\u011fl\u0131k sekt\u00f6r\u00fc hisselerini etkileyen genel piyasa belirsizlikleri yer ald\u0131. Ancak \u00f6nemli olan nokta, \u015firketin temel g\u00f6stergelerinin bu ini\u015f \u00e7\u0131k\u0131\u015flar boyunca g\u00fc\u00e7l\u00fc kalmas\u0131d\u0131r.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Analistler, HAE&#8217;nin uzun vadeli beklentileri konusunda b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser. Uzmanlar\u0131n \u00f6ng\u00f6r\u00fcleri \u015funlar:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 64-68 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %16-23 y\u00fckseli\u015f)<\/li>\n<li><strong>2026 Tahmini<\/strong>: 86-94 $ ortalama hedef (potansiyel %56-70 b\u00fcy\u00fcme)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: Plazma teknolojisi benimsenmesinin h\u0131zlanmas\u0131yla 95-110 $ aral\u0131\u011f\u0131<\/li>\n<li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: K\u00fcresel sa\u011fl\u0131k taleplerinin artmas\u0131yla 100-116 $ potansiyel<a href=\"https:\/\/stockanalysis.com\/stocks\/hae\/forecast\/\">(Analist Konsens\u00fcs\u00fc)<\/a><\/li>\n<\/ul>\n<p>Konsens\u00fcs? <strong>G\u00dc\u00c7L\u00dc AL<\/strong>. Hisseyi takip eden dokuz analist, ortalama fiyat hedefini <strong>103,56 $<\/strong> olarak belirlemi\u015f ve bu da mevcut seviyelerden yakla\u015f\u0131k %88 y\u00fckseli\u015f potansiyeline i\u015faret ediyor<a href=\"https:\/\/stocksguide.com\/en\/forecast\/Haemonetics-Corporation-US4050241003\">(StocksGuide)<\/a>.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Gelir Rehberli\u011fi<\/strong>: \u015eirket 2026 i\u00e7in %3-6 gelir d\u00fc\u015f\u00fc\u015f\u00fc bekliyor<\/li>\n<li><strong>Piyasa Konsantrasyonu<\/strong>: %80 ABD plazma don\u00f6r sistemlerine ba\u011f\u0131ml\u0131l\u0131k<\/li>\n<li><strong>Uygulama Bo\u015fluklar\u0131<\/strong>: \u0130\u015f segmentleri aras\u0131nda ge\u00e7i\u015f riskleri<\/li>\n<li><strong>Volatilite<\/strong>: G\u00fcnl\u00fck fiyat dalgalanmalar\u0131 ortalama %2,71<a href=\"https:\/\/stockinvest.us\/stock\/HAE\">(StockInvest)<\/a><\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>G\u00fc\u00e7l\u00fc Marjlar<\/strong>: %16,8 i\u015fletme marj\u0131 ile rakiplerin \u00fczerinde performans<\/li>\n<li><strong>\u0130novasyon Liderli\u011fi<\/strong>: FDA onayl\u0131 plazma toplama geli\u015ftirmeleri<\/li>\n<li><strong>Kurumsal G\u00fcven<\/strong>: B\u00fcy\u00fck yat\u0131r\u0131mc\u0131lar taraf\u0131ndan %400&#8217;\u00fcn \u00fczerinde hisse art\u0131\u015f\u0131<\/li>\n<li><strong>Geri Al\u0131m Program\u0131<\/strong>: 150 milyon $ hisse geri al\u0131m yetkisi<a href=\"https:\/\/www.ainvest.com\/news\/haemonetics-hae-dislocated-market-opportunity-earnings-strength-full-year-guidance-2508\/\">(AInvest)<\/a><\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine d\u00fczenli sabit miktarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: 6 Kas\u0131m kazan\u00e7 raporu \u00e7evresinde potansiyel giri\u015f noktalar\u0131n\u0131 izleyin<\/li>\n<li><strong>Temelleri Ara\u015ft\u0131r\u0131n<\/strong>: Hissenin arkas\u0131ndaki plazma teknolojisi hikayesini anlay\u0131n<\/li>\n<li><strong>Uygun \u00c7e\u015fitlendirme<\/strong>: HAE&#8217;yi dengeli bir sa\u011fl\u0131k portf\u00f6y\u00fcn\u00fcn par\u00e7as\u0131 olarak tutun<\/li>\n<\/ol>\n<p>Esprili t\u00fcccar bilgeli\u011fi: &#8220;HAE ticareti yapmak plazma ba\u011f\u0131\u015f\u0131 gibidir\u2014bazen hafif bir ac\u0131 hissedersiniz ama hayat kurtarmaya yard\u0131m ederken potansiyel olarak para kazan\u0131rs\u0131n\u0131z!&#8221;<\/p>\n<h2>\u2705 Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;HAE&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Emir detaylar\u0131n\u0131 iki kez kontrol edin ve onaylay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Sa\u011fl\u0131k Hisseleri \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2>\n<p>Haemonetics gibi \u015firketlere yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option, sa\u011fl\u0131k sekt\u00f6r\u00fc yat\u0131r\u0131mlar\u0131yla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile medikal inovasyon hisselerinde pozisyon almaya ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge ile KYC s\u00fcreci sayesinde h\u0131zl\u0131ca i\u015flem yapmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>Esnek Para \u00c7ekme<\/strong>: Geleneksel ve dijital dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fc analizi ve piyasa i\u00e7g\u00f6r\u00fclerine eri\u015fim<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck mebla\u011flar yat\u0131rmadan umut vadeden sa\u011fl\u0131k \u015firketlerinde kademeli pozisyonlar olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Haemonetics: Medikal Teknoloji Lideri<\/h2>\n<p>Haemonetics Corporation, ola\u011fan\u00fcst\u00fc bir hikayeye sahip k\u00fcresel bir medikal teknoloji yenilik\u00e7isidir. \u015eirket, kritik sa\u011fl\u0131k ihtiya\u00e7lar\u0131na dokunan \u00fc\u00e7 ana segmentte faaliyet g\u00f6stermektedir:<\/p>\n<ul>\n<li><strong>Plazma Operasyonlar\u0131<\/strong>: NexSys PCS sistemleri, FDA onayl\u0131 geli\u015ftirmelerle prosed\u00fcr s\u00fcrelerini sadece 33-38 dakikaya d\u00fc\u015f\u00fcren en son teknoloji plazma toplama sistemidir<a href=\"https:\/\/www.biospace.com\/haemonetics-receives-fda-clearance-for-enhancements-to-nexsys-pcs-plasma-collection-system\">(BioSpace)<\/a>.<\/li>\n<li><strong>Kan Merkezi \u00c7\u00f6z\u00fcmleri<\/strong>: Kan toplama organizasyonlar\u0131n\u0131n kan g\u00fcvenli\u011fini sa\u011flamalar\u0131na ve operasyonel verimlili\u011fi art\u0131rmalar\u0131na yard\u0131mc\u0131 olur.<\/li>\n<li><strong>Hastane Teknolojileri<\/strong>: Hemostaz tan\u0131 sistemleri, transf\u00fczyon y\u00f6netim yaz\u0131l\u0131mlar\u0131 ve h\u00fccre kurtarma sistemleri ile hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirir.<\/li>\n<\/ul>\n<p>Sistemlerinde 50 milyondan fazla ger\u00e7ek d\u00fcnya toplamas\u0131 tamamlanm\u0131\u015f ve yakla\u015f\u0131k 95 \u00fclkede varl\u0131k g\u00f6steren Haemonetics, sa\u011fl\u0131k verimlili\u011finde g\u00fcvenilir bir ortak olarak kendini kan\u0131tlam\u0131\u015ft\u0131r<a href=\"https:\/\/www.haemonetics.com\/about-us\">(Haemonetics)<\/a>.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Haemonetics&#8217;in IMPACT \u00e7al\u0131\u015fmas\u0131\u2014plazmaferez \u00fczerine en b\u00fcy\u00fck klinik denemelerden biri\u20143.443 don\u00f6r\u00fc kapsad\u0131 ve ba\u011f\u0131\u015f ba\u015f\u0131na toplanan plazma hacminde %8,2 art\u0131\u015f g\u00f6sterirken \u00fcst\u00fcn g\u00fcvenlik standartlar\u0131n\u0131 korudu<a href=\"https:\/\/www.stocktitan.net\/news\/HAE\/haemonetics-clinical-study-results-on-a-new-personalized-approach-to-v9whyyljwxi7.html\">(StockTitan)<\/a>. Bu yenilik, ba\u011f\u0131\u015f\u0131kl\u0131k bozukluklar\u0131ndan travma bak\u0131m\u0131na kadar bir\u00e7ok tedavi i\u00e7in artan k\u00fcresel plazma kaynakl\u0131 terapi talebine do\u011frudan yan\u0131t vermektedir.<\/p>\n"},"faq":[{"question":"Haemonetics Corporation hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya online ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"HAE\" sembol\u00fc ile hisseyi aray\u0131n, uygun emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylayarak sat\u0131n alma i\u015flemini tamamlay\u0131n."},{"question":"HAE hissesinin 2025-2030 fiyat tahmini nedir?","answer":"Analistlerin ortalama fiyat hedefi 2025 sonunda 64-68 $, 2026'da 86-94 $, 2028'de 95-110 $ ve 2030'da 100-116 $ aral\u0131\u011f\u0131nda olup, g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme potansiyeli \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Haemonetics Corporation'\u0131n temel i\u015f alanlar\u0131 nelerdir?","answer":"\u015eirketin \u00fc\u00e7 ana segmenti plazma operasyonlar\u0131, kan merkezi \u00e7\u00f6z\u00fcmleri ve hastane teknolojileridir."},{"question":"HAE hissesinde yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Gelir d\u00fc\u015f\u00fc\u015f\u00fc beklentisi, ABD pazar\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k, i\u015f segmentleri aras\u0131nda ge\u00e7i\u015f riskleri ve g\u00fcnl\u00fck fiyat volatilitesi ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar HAE hissesi al\u0131rken nelere dikkat etmelidir?","answer":"D\u00fczenli yat\u0131r\u0131m yaparak dolar maliyet ortalamas\u0131 uygulamak, kazan\u00e7 raporlar\u0131 gibi \u00f6nemli tarihlerde fiyat uyar\u0131lar\u0131 kurmak, \u015firketin temelini ara\u015ft\u0131rmak ve portf\u00f6y\u00fc uygun \u015fekilde \u00e7e\u015fitlendirmek \u00f6nemlidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Haemonetics Corporation hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya online ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"HAE\" sembol\u00fc ile hisseyi aray\u0131n, uygun emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylayarak sat\u0131n alma i\u015flemini tamamlay\u0131n."},{"question":"HAE hissesinin 2025-2030 fiyat tahmini nedir?","answer":"Analistlerin ortalama fiyat hedefi 2025 sonunda 64-68 $, 2026'da 86-94 $, 2028'de 95-110 $ ve 2030'da 100-116 $ aral\u0131\u011f\u0131nda olup, g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme potansiyeli \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Haemonetics Corporation'\u0131n temel i\u015f alanlar\u0131 nelerdir?","answer":"\u015eirketin \u00fc\u00e7 ana segmenti plazma operasyonlar\u0131, kan merkezi \u00e7\u00f6z\u00fcmleri ve hastane teknolojileridir."},{"question":"HAE hissesinde yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Gelir d\u00fc\u015f\u00fc\u015f\u00fc beklentisi, ABD pazar\u0131na y\u00fcksek ba\u011f\u0131ml\u0131l\u0131k, i\u015f segmentleri aras\u0131nda ge\u00e7i\u015f riskleri ve g\u00fcnl\u00fck fiyat volatilitesi ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar HAE hissesi al\u0131rken nelere dikkat etmelidir?","answer":"D\u00fczenli yat\u0131r\u0131m yaparak dolar maliyet ortalamas\u0131 uygulamak, kazan\u00e7 raporlar\u0131 gibi \u00f6nemli tarihlerde fiyat uyar\u0131lar\u0131 kurmak, \u015firketin temelini ara\u015ft\u0131rmak ve portf\u00f6y\u00fc uygun \u015fekilde \u00e7e\u015fitlendirmek \u00f6nemlidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T02:51:24+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T02:51:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\",\"name\":\"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-29T02:51:24+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T02:51:24+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T02:51:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/","name":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-29T02:51:24+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-haemonetics-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Haemonetics Corporation (HAE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Haemonetics Corporation (HAE) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":355782,"slug":"how-to-buy-haemonetics-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Haemonetics Corporation (HAE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"},"pt_AA":{"locale":"pt_AA","id":355776,"slug":"how-to-buy-haemonetics-corporation","post_title":"Como comprar a\u00e7\u00f5es da Haemonetics Corporation (HAE) - Investimento em a\u00e7\u00f5es da Haemonetics Corporation (HAE)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-haemonetics-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/355779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=355779"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/355779\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=355779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=355779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=355779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}